-
Association between Polypharmacy and Cognitive Limitations among Adults with Depression in the United States
Mar 10, 2025, 14:00 PM -
2015-2024 Pricing Advantage of First-in-Indication Non-Oncology Orphan Products Versus Late Entrants and Recent Trends
Mar 10, 2025, 14:00 PM -
Risk of Developing Diabetic Retinopathy and Diabetic Macular Edema in Patients With Insulin Therapy Vs Newer Oral Hypoglycemic Agents (SGLT2i and GLP-1)
Mar 10, 2025, 14:00 PM -
Patient Voice in Rare Disease Health Technology Assessments: Recent Trends in the Use of Qualitative Research in Reimbursement Submissions to Canada's Drug Agency
Mar 10, 2025, 14:00 PM -
Are Workforce Productivity Measures Useful for Formulary Management Decision-Making?
Mar 10, 2025, 14:00 PM -
Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic HR+ HER2- Breast Cancer
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Momelotinib for the Treatment of Adult Patients With Myelofibrosis and Anemia in Canada
Mar 10, 2025, 14:00 PM -
Disparities in Access to COPD Medications in Brazil - Impact of Geography and Socioeconomic Factors on Patient Travel Distances
Mar 10, 2025, 14:00 PM -
An Evaluation of PhlexNeuron, an Internal, Proprietary Artificial Intelligence (AI) Tool for Systematic Literature Review (SLR) Screening
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and the Economic Burden of Neovascular Age-Related Macular Degeneration (nAMD): A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Clinical Characteristics Among Patients With Crohn’s Disease Receiving First- and Second-Line Biologic Treatments in The United States
Mar 10, 2025, 14:00 PM -
From Scarcity to Strategy: Generative AI for Rare Disease Model Conceptualization
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review of the Economic Burden in Patients with Ehlers-Danlos Syndrome in the United States
Mar 10, 2025, 14:00 PM -
The Burden of Migraine in Brazil's Private Healthcare System: Results From the Brazil Migraine Real-World Evidence (BREM) Study
Mar 10, 2025, 14:00 PM -
Hydroxyurea Use and Clinical Outcomes Among Adults with Severe Sickle Cell Disease: A retrospective Cohort Study using Electronic Health Record Data
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Continuous Glucose Monitoring with Predictive Alarms for Type 1 Diabetes in Chile (T1D): Perspective of the Explicit Health Guarantees Regime.
Mar 10, 2025, 14:00 PM -
Impact of Treatment Response on Quality of Life and Health-Related Utility Values in Hepatitis: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Evaluation of the Impact of Fezolinetant vs Placebo on Indirect Costs Among Women With VMS Associated With Menopause
Mar 10, 2025, 14:00 PM -
Real-World Utilization of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults
Mar 10, 2025, 14:00 PM -
Use of Diaries to Capture Patient-Reported Outcomes in FDA New Drug Approvals (2019-2023)
Mar 10, 2025, 14:00 PM
